TRCT
GLSI icon

Tower Research Capital (TRC)’s Greenwich LifeSciences GLSI Stock Holding History

Tower Research Capital (TRC)’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Buy
1,791
+371
+26% +$9.03K ﹤0.01% 2881
2026
Q1 		$34.1K Buy
1,420
+264
+23% +$6.89K ﹤0.01% 3075
2025
Q4 		$24.3K Sell
1,156
-121
-9% -$1.27K ﹤0.01% 2959
2025
Q3 		$12.7K Sell
1,277
-1,986
-61% -$22.4K ﹤0.01% 3757
2025
Q2 		$29.6K Buy
3,263
+2,256
+224% +$21.5K ﹤0.01% 3405
2025
Q1 		$9.61K Sell
1,007
-41
-4% -$497 ﹤0.01% 3752
2024
Q4 		$11.8K Buy
1,048
+415
+66% +$5.56K ﹤0.01% 3679
2024
Q3 		$9.1K Buy
+633
New +$9.38K ﹤0.01% 3906
2024
Q2 		– Sell
-530
Closed -$10.6K – 5806
2024
Q1 		$10.6K Sell
530
-906
-63% -$11.2K ﹤0.01% 3684
2023
Q4 		$15.1K Buy
1,436
+140
+11% +$1.4K ﹤0.01% 3838
2023
Q3 		$11.5K Buy
1,296
+68
+6% +$639 ﹤0.01% 3992
2023
Q2 		$11.8K Buy
1,228
+127
+12% +$1.42K ﹤0.01% 3926
2023
Q1 		$15K Buy
1,101
+1,049
+2,017% +$16.6K ﹤0.01% 3785
2022
Q4 		$1K Buy
+52
New +$596 ﹤0.01% 5599
2022
Q3 		– Sell
-1,291
Closed -$11K – 6218
2022
Q2 		$11K Buy
1,291
+796
+161% +$9.12K ﹤0.01% 4372
2022
Q1 		$10K Sell
495
-401
-45% -$8.11K ﹤0.01% 4305
2021
Q4 		$22K Buy
896
+649
+263% +$21.7K ﹤0.01% 3562
2021
Q3 		$10K Sell
247
-41
-14% -$1.71K ﹤0.01% 4315
2021
Q2 		$13K Sell
288
-1,565
-84% -$59.2K ﹤0.01% 4221
2021
Q1 		$63K Buy
+1,853
New +$63.1K ﹤0.01% 2929

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Tower Research Capital (TRC)'s GLSI Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Greenwich LifeSciences (GLSI) stake by 26% in Q2 2026, buying an estimated $9.03K and bringing the position to 1,791 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #2881.

Tower Research Capital (TRC) first reported a position in GLSI in Q1 2021 and has held it in 20 quarters since. The position peaked at $63K in Q1 2021. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Tower Research Capital (TRC) held 1,791 shares of Greenwich LifeSciences worth $42K as of Q2 2026.
  • Tower Research Capital (TRC) bought 371 Greenwich LifeSciences shares in Q2 2026, an estimated $9.03K.
  • Greenwich LifeSciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2881 holding.
  • Tower Research Capital (TRC) first reported a position in Greenwich LifeSciences in Q1 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Greenwich LifeSciences position peaked at $63K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.